Skip to main content
Clinical Trials/NCT02668614
NCT02668614
Completed
Not Applicable

Early Detection of Skin Cancer Using Millimetre-Wave Waveguide Reflectometers

Lawson Health Research Institute0 sites60 target enrollmentFebruary 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Carcinoma, Basal Cell
Sponsor
Lawson Health Research Institute
Enrollment
60
Primary Endpoint
Positive predictive value
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Skin cancer represents a large problem in today's healthcare setting. The majority of cancer diagnoses are attributed to malignant skin diseases including its major types: basal cell carcinoma, squamous cell carcinoma and melanoma. Early diagnoses is critical given early detection of malignant lesions largely increases chances of successful treatment. The current gold standard of diagnosis is histopathological examination of biopsied skin. Biopsies are not only invasive and expensive, they have variable positive predictive value, meaning they may often be preformed unnecessarily. As such, the investigators have developed a skin scanner, which is less bulky and expensive than existing similar technologies, as a tool to evaluate skin lesions prior to determining the need for a biopsy. Their objective is to obtain information in order to validate this skin scanner in the context of its ability to accurately identify basal cell carcinoma skin lesions.

Registry
clinicaltrials.gov
Start Date
February 2016
End Date
February 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient requiring skin biopsy for suspected basal cell carcinoma skin lesion
  • 18 years of age or older

Exclusion Criteria

  • Poor english fluency, Pregnancy

Outcomes

Primary Outcomes

Positive predictive value

Time Frame: Immediately pre-biopsy

Similar Trials